Initial testing (stage 1) of temozolomide by the pediatric preclinical testing program-Reference-Cited by-同舟云学术

Initial testing (stage 1) of temozolomide by the pediatric preclinical testing program

Published:2013-01-17 Issue:5 Volume:60 Page:783-790
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Keir Stephen T.,Maris John M.,Reynolds C. Patrick,Kang Min H.,Kolb E. Anders,Gorlick Richard,Lock Richard,Carol Hernan,Morton Christopher L.,Wu Jianrong,Kurmasheva Raushan T.,Houghton Peter J.,Smith Malcolm A.

Funder

National Cancer Institute

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.24368/fullpdf

Reference66 articles.

1. Temozolomide in malignant gliomas: Current use and future targets;Villano;Cancer Chemother Pharmacol,2009

2. Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856);Newlands;Br J Cancer,1992

3. Treatment of pituitary neoplasms with temozolomide: A review;Syro;Cancer.,2010

4. Antitumor imidazotetrazines-XV. Role of guanine O6 alkylation in the mechanism of cytotoxicity of imidazotetrazinones;Tisdale;Biochem Pharmacol,1987

5. Involvement of the mismatch repair system in temozolomide-induced apoptosis;D'Atri;Mol Pharmacol,1998

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Imidazotetrazine Evades Known Resistance Mechanisms and Is Effective against Temozolomide-Resistant Brain Cancer in Cell Culture;ACS Chemical Biology;2022-02-04

2. Systematic Establishment of Robustness and Standards in Patient-Derived Xenograft Experiments and Analysis;Cancer Research;2020-03-09

3. Temozolomide and Pazopanib Combined with FOLFOX Regressed a Primary Colorectal Cancer in a Patient-derived Orthotopic Xenograft Mouse Model;Translational Oncology;2020-03

4. Systematic Establishment of Robustness and Standards in Patient-Derived Xenograft Experiments and Analysis;2019-10-02

5. Temozolomide targets and arrests a doxorubicin-resistant follicular dendritic-cell sarcoma patient-derived orthotopic xenograft mouse model;Tissue and Cell;2019-06